https://www.selleckchem.com/pr....oducts/LDE225(NVP-LD
0 (95% CI -8.5 to 4.6; p=0.56) at rest and -8.0 (-17.3 to 1.3; p=0.093) on arm activity. There were no between-group differences in the secondary outcomes or adverse events that exceeded the MID. In our secondary comparison (ASD vs exercise therapy), the mean differences between groups (ASD minus exercise therapy) in pain VAS were 1.0 (-5.6 to 7.6; p=0.77) at rest and -3.9 (-12.8 to 5.1; p=0.4 on arm activity. There were no significant between-group differences for the secondary outcomes or adverse events. ASD provided no b
Like
Comment
Share
